Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994–2002)
Authors:
- Sarah PayneSPSarah Payne
- Lisa G. BarberLBLisa G. Barber
- Lillian E. DudaLDLillian E. Duda
- Carolyn J. HenryCHCarolyn J. Henry
- Glenna E. MauldinGMGlenna E. Mauldin
- Angela E. FrimbergerAFAngela E. Frimberger
- Susan M. CotterSCSusan M. Cotter
- Antony S. MooreAMAntony S. Moore
- 1 August 2004
- journal article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 225 (3) , 401-408
Abstract
Objective—To determine the prognostic factors for survival and tumor recurrence in dogs with cutaneous mast cell tumors (MCTs) in the perineal and inguinal regions treated surgically with or without adjunctive radiation therapy, chemotherapy, or both. Design—Retrospective study. Animals—68 dogs. Procedure—Medical records of dogs with histologically confirmed MCTs in the perineal region, inguinal region, or both treated surgically with or without adjunctive radiation therapy, chemotherapy, or both were reviewed. Results—Mean tumor-free interval was 1,635 days (median not reached), and 1- and 2-year tumor-free rates were 79% and 71%, respectively. Median survival time was 1,111 days (mean, 1,223 days), and 1- and 2-year survival rates were 79% and 61%, respectively. Factors that negatively influenced survival time were age at diagnosis, tumor recurrence, and treatment with lomustine. Conclusions and Clinical Relevance—Results indicated that dogs with MCTs in the inguinal and perineal regions, if appropriately treated, may have survival times and tumor-free intervals similar to dogs with MCTs in other locations. ( J Am Vet Med Assoc 2004;225:401–408)Keywords
This publication has 12 references indexed in Scilit:
- Recurrence Rates and Sites for Grade II Canine Cutaneous Mast Cell Tumors Following Complete Surgical ExcisionJournal of the American Animal Hospital Association, 2002
- Treatment of Canine Mast Cell Tumors with CCNU (Lomustine)Journal of Veterinary Internal Medicine, 1999
- Lomustine (CCNU) for the Treatment of Resistant Lymphoma in DogsJournal of Veterinary Internal Medicine, 1999
- Prednisone and Vinblastine Chemotherapy for Canine Mast Cell Tumor—41 Cases (1992–1997)Journal of Veterinary Internal Medicine, 1999
- RADIATION THERAPY FOR INCOMPLETELY RESECTED CANINE MAST CELL TUMORSVeterinary Radiology & Ultrasound, 1998
- Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993)Journal of the American Animal Hospital Association, 1997
- A Prospective Study of Radiation Therapy for the Treatment of Grade 2 Mast Cell Tumors in 32 DogsJournal of Veterinary Internal Medicine, 1996
- Skin Tumors in Domestic Animals. Data from 12 United States and Canadian Colleges of Veterinary Medicine 2JNCI: Journal of the National Cancer Institute, 1973
- The prognosis following surgical removal of mastocytomas in dogsJournal of Small Animal Practice, 1973
- Further Observations on Neoplasms in Dogs, with Particular Reference to Site of Origin and MalignancyBritish Veterinary Journal, 1954